-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-11-08
Values as of: 2024-11-08
The investment seeks to track the investment results of the Dow Jones U.S. Select Health Care Providers Index composed of U.S. equities in the healthcare providers sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare providers sector of the U.S. equity market. The fund may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Company Website : www.ishares.com
Currency: USD
Country : USA
Inception Date: 01/05/2006
Primary Benchmark: DJ US Select HC Providers TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.44%
Management Expense Ratio: 0.43 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| 3020-OL:HK | X DBMSCIUSA | 7.75 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR.. | 0.13 % |
-0.88 (-0.59%) |
USD 40.46B |
| FHLC | Fidelity® MSCI Health Care In.. | 0.08 % |
-0.29 (-0.41%) |
USD 2.91B |
| FXH | First Trust Health Care AlphaD.. | 0.63 % |
+0.65 (+0.58%) |
USD 1.19B |
| XHE | SPDR® S&P Health Care Equipme.. | 0.35 % |
+0.78 (+0.84%) |
USD 0.22B |
| IDNA | iShares Genomics Immunology an.. | 0.00 % |
+0.15 (+0.57%) |
USD 0.15B |
| SBIO | ALPS Medical Breakthroughs ETF | 0.50 % |
+0.37 (+0.87%) |
USD 0.13B |
| XHS | SPDR® S&P Health Care Service.. | 0.35 % |
+2.06 (+2.13%) |
USD 0.08B |
| HTEC | Robo Global® Healthcare Techn.. | 0.00 % |
+0.27 (+0.91%) |
USD 0.06B |
| BBP | Virtus LifeSci Biotech Product.. | 0.79 % |
-0.45 (-0.66%) |
USD 0.02B |
| BBC | Virtus LifeSci Biotech Clinica.. | 0.79 % |
+0.29 (+0.93%) |
USD 0.01B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| MSSS | 9.54 % | 0.00 % |
N/A |
N/A | |
| LCR | Leuthold Core ETF | 0.00 % | 0.00 % |
+0.04 (+0%) |
USD 0.09B |
| Market Performance vs. Industry/Classification (Health) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -79.15% | 10% | F | 3% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -79.15% | 10% | F | 4% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -77.90% | 10% | F | 3% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -77.90% | 10% | F | 4% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -70.36% | 10% | F | 7% | C- | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -70.36% | 10% | F | 8% | B- | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 6.69% | 67% | D+ | 58% | F | ||
| Dividend Return | 7.32% | 67% | D+ | 53% | F | ||
| Total Return | 0.62% | 63% | D | 15% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 21.44% | 43% | F | 51% | F | ||
| Risk Adjusted Return | 34.12% | 57% | F | 51% | F | ||
| Market Capitalization | 0.52B | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
